LABORATORIOS ALPHA SAN IGNACIO PHARMA S.L. - ALPHASIP

Their core work

ALPHASIP is a Spanish SME based in Zaragoza that develops rapid diagnostic devices for infectious diseases, with their flagship product targeting pneumonia detection. They specialize in integrating micro-fabricated sensor technologies into point-of-care medical diagnostics. Their work sits at the intersection of semiconductor manufacturing processes (ECSEL projects) and clinical diagnostics, enabling them to translate microfabrication advances into affordable, fast-result medical testing devices.

What they specialise in

How they've shifted over time

ALPHASIP began with a tight focus on their core pneumonia diagnostic product, progressing through the classic SME Instrument pipeline — Phase 1 feasibility (2014) followed by Phase 2 full development (2015-2019) with substantial EU funding. In parallel, they expanded into broader micro-fabrication and sensor technology through ECSEL consortium projects (InForMed, SILENSE), suggesting a strategy to absorb manufacturing know-how and diversify their sensor platform. Their trajectory moved from single-product diagnostics toward a broader sensor technology competence applicable beyond pneumonia.

ALPHASIP appears to be broadening from a single-product diagnostic company toward a platform sensor technology SME, potentially applying microfabrication expertise to new clinical or industrial sensing applications.

How they like to work

ALPHASIP balances leadership and partnership equally — they coordinated both PneumoSIP phases (driving their own product development) while joining large ECSEL consortia (InForMed, SILENSE) as a specialist participant. The ECSEL projects brought them into very large consortia (explaining 68 partners across 13 countries), where they likely served as a diagnostics application partner rather than a technology driver. This dual approach suggests they are comfortable both leading focused product work and contributing domain expertise within large multi-partner initiatives.

Through four projects, ALPHASIP has worked with 68 unique partners across 13 countries, a network largely built through participation in large ECSEL semiconductor consortia. Their geographic reach spans much of Europe, though their coordinated projects were likely smaller Spain-centered efforts.

What sets them apart

ALPHASIP occupies a specific niche as a diagnostics SME that understands both the clinical application side (what doctors and hospitals need) and the semiconductor fabrication side (how sensors are actually made at scale). This dual literacy makes them a valuable bridge partner in projects that need to connect chip-level innovation with real-world medical testing. For consortium builders, they bring the end-user validation perspective — they can test whether a new sensor technology actually works in a clinical diagnostic context.

Highlights from their portfolio

• PNEUMOSIP
  Their flagship project with EUR 3.4M in EC funding — a full SME Instrument Phase 2 effort to develop a cost-effective rapid pneumonia diagnostic, representing 89% of their total H2020 funding.
• InForMed
  Large ECSEL pilot line project for micro-fabricated medical devices, connecting ALPHASIP to the European semiconductor ecosystem and advanced manufacturing capabilities.